300583 赛托生物
已收盘 11-06 15:00:00
资讯
新帖
简况
赛托生物（300583）11月2日主力资金净买入296.70万元
证券之星 · 11-02
赛托生物（300583）11月2日主力资金净买入296.70万元
股市必读：赛托生物三季报 - 第三季度单季净利润同比增长116.83%
证券之星 · 11-02
股市必读：赛托生物三季报 - 第三季度单季净利润同比增长116.83%
赛托生物（300583）2026年三季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 10-31
赛托生物（300583）2026年三季报简析：营收净利润同比双双增长，盈利能力上升
赛托生物(300583.SZ)发布前三季度业绩，归母净利润3301.14万元，同比增长147.68%
智通财经 · 10-29
赛托生物(300583.SZ)发布前三季度业绩，归母净利润3301.14万元，同比增长147.68%
赛托生物（300583）披露2026年三季度报告，10月29日股价下跌2.56%
证券之星 · 10-29
赛托生物（300583）披露2026年三季度报告，10月29日股价下跌2.56%
赛托生物获得实用新型专利授权：“一种带有氮气保护机构的防爆型全自动下卸料离心机”
证券之星 · 10-29
赛托生物获得实用新型专利授权：“一种带有氮气保护机构的防爆型全自动下卸料离心机”
赛托生物（300583）披露子公司收到药品GMP符合性检查告知书，9月28日股价下跌0.07%
证券之星 · 09-28
赛托生物（300583）披露子公司收到药品GMP符合性检查告知书，9月28日股价下跌0.07%
赛托生物(300583)6月30日股东户数1.28万户，较上期减少6.33%
证券之星 · 08-29
赛托生物(300583)6月30日股东户数1.28万户，较上期减少6.33%
赛托生物（300583）披露2026年半年度报告及其摘要，8月28日股价下跌0.31%
证券之星 · 08-28
赛托生物（300583）披露2026年半年度报告及其摘要，8月28日股价下跌0.31%
图解赛托生物中报：第二季度单季净利润同比增长205.69%
证券之星 · 08-28
图解赛托生物中报：第二季度单季净利润同比增长205.69%
赛托生物(300583.SZ)：糠酸氟替卡松化学原料药上市申请获批
智通财经 · 07-22
赛托生物(300583.SZ)：糠酸氟替卡松化学原料药上市申请获批
赛托生物（300583）披露2025年年度权益分派实施公告，7月7日股价下跌3.48%
证券之星 · 07-07
赛托生物（300583）披露2025年年度权益分派实施公告，7月7日股价下跌3.48%
赛托生物获得实用新型专利授权：“一种压缩空气储气罐自动排水装置”
证券之星 · 07-04
赛托生物获得实用新型专利授权：“一种压缩空气储气罐自动排水装置”
赛托生物（300583）披露重大诉讼公告，7月1日股价上涨4.36%
证券之星 · 07-01
赛托生物（300583）披露重大诉讼公告，7月1日股价上涨4.36%
赛托生物（300583）披露回购公司股份实施完成暨股份变动公告，6月29日股价上涨3.26%
证券之星 · 06-29
赛托生物（300583）披露回购公司股份实施完成暨股份变动公告，6月29日股价上涨3.26%
赛托生物：公司已于2026年5月启动股份回购计划
证券之星 · 06-17
赛托生物：公司已于2026年5月启动股份回购计划
赛托生物：2026年一季度公司已实现扭亏为盈
证券之星 · 06-04
赛托生物：2026年一季度公司已实现扭亏为盈
股市必读：赛托生物（300583）6月1日董秘有最新回复
证券之星 · 06-02
股市必读：赛托生物（300583）6月1日董秘有最新回复
赛托生物（300583）披露首次回购公司股份公告，5月28日股价下跌0.69%
证券之星 · 05-28
赛托生物（300583）披露首次回购公司股份公告，5月28日股价下跌0.69%
赛托生物：公司副产品甲酯为大豆油混合脂肪酸甲酯
证券之星 · 05-28
赛托生物：公司副产品甲酯为大豆油混合脂肪酸甲酯
加载更多
公司概况
公司名称：
山东赛托生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2017-01-06
主营业务：
山东赛托生物科技股份有限公司的主营业务是应用基因工程技术和微生物转化技术制造并销售甾体药物原料和中间体。公司的主要产品是雄烯二酮（4-AD）、雄二烯二酮（ADD）、9-羟基雄烯二酮（9OH-AD）、四烯物（3TR）、甲羟环氧孕酮（8DM）等甾体药物原料及中间体。
发行价格：
40.29
{"stockData":{"symbol":"300583","market":"SZ","secType":"STK","nameCN":"赛托生物","latestPrice":11.2,"timestamp":1793948610000,"preClose":11.4,"halted":0,"volume":3756452,"delay":0,"changeRate":-0.0175,"floatShares":186000000,"shares":190000000,"eps":0.1534,"marketStatus":"已收盘","change":-0.2,"latestTime":"11-06 15:00:00","open":11.15,"high":11.34,"low":11.03,"amount":42065700,"amplitude":0.0272,"askPrice":11.21,"askSize":8,"bidPrice":11.2,"bidSize":264,"shortable":0,"etf":0,"ttmEps":0.1534,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1794187800000},"marketStatusCode":5,"adr":0,"adjPreClose":11.4,"symbolType":"stock","openAndCloseTimeList":[[1793928600000,1793935800000],[1793941200000,1793948400000]],"highLimit":12.54,"lowLimit":10.26,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":189702126,"isCdr":false,"pbRate":1.23,"roa":"--","peRate":73.011734,"roe":"1.86%","epsLYR":-0.39,"committee":0.794271,"marketValue":2125000000,"turnoverRate":0.0202,"status":1,"floatMarketCap":2085000000},"requestUrl":"/m/hq/s/300583","defaultTab":"news","newsList":[{"id":"2680731801","title":"赛托生物（300583）11月2日主力资金净买入296.70万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2680731801","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680731801?lang=zh_cn&edition=full","pubTime":"2026-11-02 15:46","pubTimestamp":1793605588,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年11月2日收盘，赛托生物报收于10.91元，下跌0.82%，换手率3.93%，成交量7.31万手，成交额7887.87万元。11月2日的资金流向数据方面，主力资金净流入296.7万元，占总成交额3.76%，游资资金净流入1140.58万元，占总成交额14.46%，散户资金净流出1437.28万元，占总成交额18.22%。赛托生物主营业务：应用基因工程技术和微生物转化技术制造并销售甾体药物原料和中间体。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200017793.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680788009","title":"股市必读：赛托生物三季报 - 第三季度单季净利润同比增长116.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2680788009","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680788009?lang=zh_cn&edition=full","pubTime":"2026-11-02 07:12","pubTimestamp":1793574738,"startTime":"0","endTime":"0","summary":"业绩披露要点：2026年前三季度归母净利润3301.14万元，同比上升147.68%；第三季度单季度归母净利润278.4万元，同比上升116.83%。公司公告汇总2026年三季度报告2026年第三季度营业收入2.57亿元，同比增长6.58%；归母净利润278.4万元，同比增长116.83%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110200001908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679222978","title":"赛托生物（300583）2026年三季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2679222978","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679222978?lang=zh_cn&edition=full","pubTime":"2026-10-31 11:53","pubTimestamp":1793418797,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期赛托生物发布2026年三季报。截至本报告期末，公司营业总收入8.7亿元，同比上升16.13%，归母净利润3301.14万元，同比上升147.68%。按单季度数据看，第三季度营业总收入2.57亿元，同比上升6.58%，第三季度归母净利润278.4万元，同比上升116.83%。本报告期赛托生物盈利能力上升，毛利率同比增幅96.17%，净利率同比增幅138.35%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100025569.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679894122","title":"赛托生物(300583.SZ)发布前三季度业绩，归母净利润3301.14万元，同比增长147.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679894122","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679894122?lang=zh_cn&edition=full","pubTime":"2026-10-29 22:55","pubTimestamp":1793285712,"startTime":"0","endTime":"0","summary":"智通财经APP讯，赛托生物(300583.SZ)发布2026年三季度报告，前三季度，公司实现营业收入8.7亿元，同比增长16.13%。归属于上市公司股东的净利润3301.14万元，同比增长147.68%。归属于上市公司股东的扣除非经常性损益的净利润3077.44万元，同比增长142.51%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1515613.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679895492","title":"赛托生物（300583）披露2026年三季度报告，10月29日股价下跌2.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679895492","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679895492?lang=zh_cn&edition=full","pubTime":"2026-10-29 22:40","pubTimestamp":1793284802,"startTime":"0","endTime":"0","summary":"截至2026年10月29日收盘，赛托生物报收于11.8元，较前一交易日下跌2.56%，最新总市值为22.38亿元。该股当日开盘12.11元，最高12.23元，最低11.7元，成交额达3607.52万元，换手率为1.63%。近日，山东赛托生物科技股份有限公司披露《2026年第三季度报告》。公告显示，本报告期营业收入为257,305,626.08元，同比增长6.58%；归属于上市公司股东的净利润为2,784,020.49元，同比增长116.83%。年初至报告期末营业收入为870,037,153.75元，同比增长16.13%；归属于上市公司股东的净利润为33,011,378.75元，同比增长147.68%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900063698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679240754","title":"赛托生物获得实用新型专利授权：“一种带有氮气保护机构的防爆型全自动下卸料离心机”","url":"https://stock-news.laohu8.com/highlight/detail?id=2679240754","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679240754?lang=zh_cn&edition=full","pubTime":"2026-10-29 20:27","pubTimestamp":1793276843,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示赛托生物新获得一项实用新型专利授权，专利名为“一种带有氮气保护机构的防爆型全自动下卸料离心机”，专利申请号为CN202522005158.4，授权日为2026年10月27日。今年以来赛托生物新获得专利授权6个。通过天眼查大数据分析，山东赛托生物科技股份有限公司共对外投资了13家企业，参与招投标项目489次；财产线索方面有商标信息24条，专利信息80条，著作权信息6条；此外企业还拥有行政许可17个。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900056021.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670225510","title":"赛托生物（300583）披露子公司收到药品GMP符合性检查告知书，9月28日股价下跌0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670225510","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670225510?lang=zh_cn&edition=full","pubTime":"2026-09-28 22:36","pubTimestamp":1790606185,"startTime":"0","endTime":"0","summary":"截至2026年9月28日收盘，赛托生物报收于13.51元，较前一交易日下跌0.07%，最新总市值为25.63亿元。该股当日开盘13.54元，最高13.85元，最低13.45元，成交额达4970.21万元，换手率为1.97%。近日，山东赛托生物科技股份有限公司控股子公司山东斯瑞药业有限公司收到山东省药品监督管理局签发的《药品GMP符合性检查告知书》，检查范围为原料药01车间01综合生产线，检查时间为2026年7月22日至7月24日，检查结论为符合《药品生产质量管理规范》要求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800035315.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663012999","title":"赛托生物(300583)6月30日股东户数1.28万户，较上期减少6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663012999","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663012999?lang=zh_cn&edition=full","pubTime":"2026-08-29 17:18","pubTimestamp":1787995087,"startTime":"0","endTime":"0","summary":"证券之星消息，近日赛托生物披露，截至2026年6月30日公司股东户数为1.28万户，较3月31日减少865.0户，减幅为6.33%。在化学制药行业个股中，赛托生物股东户数低于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年3月31日至2026年6月30日，赛托生物区间跌幅为20.58%，在此期间股东户数减少865.0户，减幅为6.33%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900023832.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662091276","title":"赛托生物（300583）披露2026年半年度报告及其摘要，8月28日股价下跌0.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662091276","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662091276?lang=zh_cn&edition=full","pubTime":"2026-08-28 22:39","pubTimestamp":1787927941,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，赛托生物报收于12.97元，较前一交易日下跌0.31%，最新总市值为24.6亿元。该股当日开盘13.01元，最高13.07元，最低12.87元，成交额达2766.79万元，换手率为1.15%。近日，赛托生物发布第四届董事会第十六次会议决议公告。公告指出，公司2026年半年度报告真实、准确、完整地反映了经营状况；募集资金使用合规，无违规情形；报告期内不存在控股股东及其他关联方非经营性资金占用及对外担保情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800055395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662256062","title":"图解赛托生物中报：第二季度单季净利润同比增长205.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662256062","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662256062?lang=zh_cn&edition=full","pubTime":"2026-08-28 19:12","pubTimestamp":1787915543,"startTime":"0","endTime":"0","summary":"证券之星消息，赛托生物2026年中报显示，上半年度公司主营收入6.13亿元，同比上升20.67%；归母净利润3022.74万元，同比上升157.37%；扣非净利润2927.84万元，同比上升154.74%；其中2026年第二季度，公司单季度主营收入2.85亿元，同比上升14.83%；单季度归母净利润2661.08万元，同比上升205.69%；单季度扣非净利润2756.95万元，同比上升207.41%；负债率39.22%，投资收益328.79万元，财务费用1699.9万元，毛利率25.43%。财报数据概要请见下图:本文数据来源于赛托生物2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082800044626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653375846","title":"赛托生物(300583.SZ)：糠酸氟替卡松化学原料药上市申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2653375846","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653375846?lang=zh_cn&edition=full","pubTime":"2026-07-22 16:27","pubTimestamp":1784708834,"startTime":"0","endTime":"0","summary":"智通财经APP讯，赛托生物(300583.SZ)发布公告，公司控股子公司山东斯瑞药业有限公司近日收到国家药品监督管理局签发的糠酸氟替卡松《化学原料药上市申请批准通知书》，糠酸氟替卡松是一种强效的糖皮质激素，用于鼻喷剂，可治疗2岁及2岁以上季节性和常年性过敏性鼻炎;用于吸入粉雾剂，可治疗哮喘和慢性阻塞性肺疾病(COPD)。公司化学原料药糠酸氟替卡松获得《化学原料药上市申请批准通知书》，表明该原料药已符合国家相关药品审评技术标准，本次获批将进一步丰富公司的产品线，有利于提升公司在化学原料药领域的市场竞争力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1470864.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","IPOS","300583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649986322","title":"赛托生物（300583）披露2025年年度权益分派实施公告，7月7日股价下跌3.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2649986322","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649986322?lang=zh_cn&edition=full","pubTime":"2026-07-07 17:34","pubTimestamp":1783416897,"startTime":"0","endTime":"0","summary":"截至2026年7月7日收盘，赛托生物报收于11.93元，较前一交易日下跌3.48%，最新总市值为22.63亿元。近日，赛托生物发布《2025年年度权益分派实施公告》。公告显示，公司2025年年度权益分派方案为：以总股本189,702,126股剔除回购股份2,388,580股后，按187,313,546股为基数，向全体股东每10股派发现金红利0.050637元（含税），现金分红总额948,510.63元不变。分配方案实施后，按总股本折算的每10股现金分红为0.049999元（含税）。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700029985.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648660613","title":"赛托生物获得实用新型专利授权：“一种压缩空气储气罐自动排水装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2648660613","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648660613?lang=zh_cn&edition=full","pubTime":"2026-07-04 03:41","pubTimestamp":1783107714,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示赛托生物新获得一项实用新型专利授权，专利名为“一种压缩空气储气罐自动排水装置”，专利申请号为CN202521932157.8，授权日为2026年6月19日。今年以来赛托生物新获得专利授权3个。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070400002298.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648351421","title":"赛托生物（300583）披露重大诉讼公告，7月1日股价上涨4.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648351421","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648351421?lang=zh_cn&edition=full","pubTime":"2026-07-01 18:17","pubTimestamp":1782901036,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，赛托生物报收于11.72元，较前一交易日上涨4.36%，最新总市值为22.23亿元。近日，赛托生物披露《关于公司重大诉讼的公告》。公告显示，山东赛托生物科技股份有限公司作为原告，就技术秘密被侵犯事宜向山东省高级人民法院提起民事诉讼，法院已立案受理。公司称被告通过不正当手段获取并使用其技术秘密，已构成商业秘密侵权。目前案件尚未开庭审理，预计不会对公司经营造成重大不利影响，具体影响以法院判决为准。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100035929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647378025","title":"赛托生物（300583）披露回购公司股份实施完成暨股份变动公告，6月29日股价上涨3.26%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647378025","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647378025?lang=zh_cn&edition=full","pubTime":"2026-06-29 18:15","pubTimestamp":1782728147,"startTime":"0","endTime":"0","summary":"截至2026年6月29日收盘，赛托生物报收于11.41元，较前一交易日上涨3.26%，最新总市值为21.65亿元。近日，赛托生物发布《关于回购公司股份实施完成暨股份变动公告》。公告显示，公司于2026年3月6日审议通过回购股份方案，拟用于员工持股计划或股权激励，回购资金总额不低于1,500万元且不超过3,000万元，回购价格不超过21.98元/股。回购股份将用于员工持股计划或股权激励，若三年内未使用则依法注销。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900029747.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644746295","title":"赛托生物：公司已于2026年5月启动股份回购计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2644746295","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644746295?lang=zh_cn&edition=full","pubTime":"2026-06-17 20:48","pubTimestamp":1781700527,"startTime":"0","endTime":"0","summary":"证券之星消息，赛托生物06月17日在投资者关系平台上答复投资者关心的问题。公司高度重视市值表现及投资者回报，公司已于2026年5月启动股份回购计划，截至6月3日累计回购190万股，后续回购仍在持续推进中；同时公司经营基本面持续向好，一季度营收同比增长26.24%并实现扭亏为盈。公司管理层将持续聚焦主业发展，以经营业绩提升带动市值回归合理水平，切实维护广大投资者利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700039288.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640515058","title":"赛托生物：2026年一季度公司已实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2640515058","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640515058?lang=zh_cn&edition=full","pubTime":"2026-06-04 20:48","pubTimestamp":1780577320,"startTime":"0","endTime":"0","summary":"证券之星消息，赛托生物06月03日在投资者关系平台上答复投资者关心的问题。感谢您对公司的长期关注与支持。作为公司的长期投资者，您对股价表现和公司发展的关切，我们感同身受，也深知大家所承受的压力。目前公司正按计划实施1500万-3000万元的股份回购，用于后续激励或持股计划。股价稳定的根本在于经营业绩。2026年一季度公司已实现扭亏为盈，管理层将继续深耕主业，努力提升盈利能力和股东回报。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400039310.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640696921","title":"股市必读：赛托生物（300583）6月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2640696921","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2640696921?lang=zh_cn&edition=full","pubTime":"2026-06-02 02:45","pubTimestamp":1780339513,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，赛托生物报收于13.18元，上涨2.57%，换手率2.1%，成交量3.91万手，成交额5130.3万元。董秘最新回复投资者： 5月26日咨询的问题，为什么不及时回复，这效率不太高。交易信息汇总资金流向6月1日主力资金净流出98.76万元；游资资金净流出165.08万元；散户资金净流入263.85万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200002106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638661467","title":"赛托生物（300583）披露首次回购公司股份公告，5月28日股价下跌0.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638661467","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638661467?lang=zh_cn&edition=full","pubTime":"2026-05-28 17:45","pubTimestamp":1779961537,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，赛托生物报收于13.01元，较前一交易日下跌0.69%，最新总市值为24.68亿元。该股当日开盘13.09元，最高13.23元，最低12.68元，成交额达5492.71万元，换手率为2.28%。2026年5月28日，山东赛托生物科技股份有限公司发布《关于首次回购公司股份的公告》。本次回购符合相关法律法规及公司回购方案的规定。公司后续将根据市场情况继续实施回购计划，并及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800032062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300583","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638663135","title":"赛托生物：公司副产品甲酯为大豆油混合脂肪酸甲酯","url":"https://stock-news.laohu8.com/highlight/detail?id=2638663135","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2638663135?lang=zh_cn&edition=full","pubTime":"2026-05-28 15:54","pubTimestamp":1779954846,"startTime":"0","endTime":"0","summary":"证券之星消息，赛托生物05月28日在投资者关系平台上答复投资者关心的问题。公司副产品甲酯为大豆油混合脂肪酸甲酯，与电子级甲酯在物理化学性质、生产工艺和应用领域存在本质差异，植物甾醇亦然。公司坚守主业，利用合成生物技术与基因工程技术为全球生命健康产业持续贡献力量。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800025200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300583"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1794092819688,"stockEarnings":[{"period":"1week","weight":0.0182},{"period":"1month","weight":-0.1825},{"period":"3month","weight":-0.1223},{"period":"6month","weight":-0.2804},{"period":"1year","weight":-0.2686},{"period":"ytd","weight":-0.1816}],"compareEarnings":[{"period":"1week","weight":0.0139},{"period":"1month","weight":-0.0502},{"period":"3month","weight":-0.0738},{"period":"6month","weight":-0.127},{"period":"1year","weight":-0.0895},{"period":"ytd","weight":-0.0805}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"山东赛托生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"14455人(较上一季度增加12.88%)","perCapita":"12877股","listingDate":"2017-01-06","address":"山东省菏泽市定陶区东外环路南段","registeredCapital":"18970万元","survey":" 山东赛托生物科技股份有限公司的主营业务是应用基因工程技术和微生物转化技术制造并销售甾体药物原料和中间体。公司的主要产品是雄烯二酮（4-AD）、雄二烯二酮（ADD）、9-羟基雄烯二酮（9OH-AD）、四烯物（3TR）、甲羟环氧孕酮（8DM）等甾体药物原料及中间体。","listedPrice":40.29},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"赛托生物(300583)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供赛托生物(300583)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"赛托生物,300583,赛托生物股票,赛托生物股票老虎,赛托生物股票老虎国际,赛托生物行情,赛托生物股票行情,赛托生物股价,赛托生物股市,赛托生物股票价格,赛托生物股票交易,赛托生物股票购买,赛托生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"赛托生物(300583)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供赛托生物(300583)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}